{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T16:41:06Z","timestamp":1768063266786,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40258-025-00999-0","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T09:21:59Z","timestamp":1756113719000},"page":"217-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson\u2019s Disease in Egypt"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7426-4285","authenticated-orcid":false,"given":"Hesham","family":"Radwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeiad Yousry","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Elserry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen T.","family":"Alkarras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7012-5907","authenticated-orcid":false,"given":"Ali","family":"Shalash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3662-159X","authenticated-orcid":false,"given":"Zahraa Hassan","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour Walid","family":"Noureldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-6093","authenticated-orcid":false,"given":"Andrew","family":"Metry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Kamel","family":"Basha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"999_CR1","doi-asserted-by":"crossref","unstructured":"Bucur M, Papagno C. Deep brain stimulation in Parkinson disease\u202f: a meta-analysis of the long\u2014term neuropsychological outcomes. Neuropsychol Rev. Springer US; 2023.","DOI":"10.1007\/s11065-022-09540-9"},{"key":"999_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031851","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031851.","journal-title":"Int J Mol Sci"},{"key":"999_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H, et al. Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health. 2021. https:\/\/doi.org\/10.3389\/fpubh.2021.776847.","journal-title":"Front Public Health"},{"key":"999_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40801-023-00410-1","volume":"11","author":"KR Chaudhuri","year":"2024","unstructured":"Chaudhuri KR, Philippe J, Per A, Susanna O, Josefa L, Alobaidi A, et al. Economic burden of Parkinson\u2019s disease: a multinational, real\u2014world, cost-of-illness study. Drugs Real World Outcomes. 2024;11:1\u201311.","journal-title":"Drugs Real World Outcomes"},{"key":"999_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/mds.23467","volume":"26","author":"B Post","year":"2011","unstructured":"Post B, Muslimovic D, van Geloven N, Speelman JD, Schmand B, de Haan RJ. Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson\u2019s disease. Mov Disord. 2011;26:449\u201356.","journal-title":"Mov Disord"},{"key":"999_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40258-023-00848-y","volume":"22","author":"A Sasidharan","year":"2024","unstructured":"Sasidharan A, Bagepally BS, Kumar SS. Cost effectiveness of deep brain stimulation for Parkinson\u2019s Disease: a systematic review. Appl Health Econ Health Policy. 2024;22:181\u201392.","journal-title":"Appl Health Econ Health Policy"},{"key":"999_CR7","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s40263-022-00963-9","volume":"36","author":"A Antonini","year":"2022","unstructured":"Antonini A, Pahwa R, Odin P, Isaacson SH, Merola A, Wang L, et al. Comparative effectiveness of device-aided therapies on quality of life and off-time in advanced Parkinson\u2019s disease: a systematic review and Bayesian network meta-analysis. CNS Drugs. 2022;36:1269\u201383.","journal-title":"CNS Drugs"},{"key":"999_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1212\/WNL.0b013e31825dcdc1","volume":"79","author":"FM Weaver","year":"2012","unstructured":"Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, et al. Randomized trial of deep brain stimulation for Parkinson\u2019s disease: thirty-six-month outcomes. Neurology. 2012;79:55\u20136.","journal-title":"Neurology"},{"key":"999_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa060281","volume":"355","author":"G Deuschl","year":"2006","unstructured":"Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Sch\u00e4fer H, B\u00f6tzel K, et al. A randomized trial of deep-brain stimulation for Parkinson\u2019s disease. N Engl J Med. 2006;355:896\u2013908.","journal-title":"N Engl J Med"},{"key":"999_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1474-4422(10)70093-4","volume":"9","author":"A Williams","year":"2010","unstructured":"Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson\u2019s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9:581\u201391.","journal-title":"Lancet Neurol"},{"key":"999_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(11)70308-8","volume":"11","author":"MS Okun","year":"2012","unstructured":"Okun MS, Gallo BV, Mandybur G, Jagid J, Foote KD, Revilla FJ, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson\u2019s disease: an open-label randomised controlled trial. Lancet Neurol. 2012;11:140\u20139.","journal-title":"Lancet Neurol"},{"key":"999_CR12","doi-asserted-by":"crossref","unstructured":"Bratsos SP, Karponis D, Saleh SN. Efficacy and safety of deep brain stimulation in the treatment of Parkinson\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. Cureus. 2018;10:e3474.","DOI":"10.7759\/cureus.3474"},{"key":"999_CR13","unstructured":"Deep brain stimulation for Parkinson\u2019s disease. Interventional procedures guidance [IPG19]. National Institute for Health and Clinical Excellence. 2003."},{"key":"999_CR14","unstructured":"Parkinson\u2019s disease in adults NICE guideline [NG71]. National Institute for Health and Clinical Excellence. 2017."},{"key":"999_CR15","unstructured":"Halli-Tierney AD, Luker J, Carroll DG. Parkinson disease. AAFP. 2020;102."},{"key":"999_CR16","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/mds.26740","volume":"31","author":"J Dams","year":"2016","unstructured":"Dams J, Balzer-Geldsetzer M, Siebert U, Deuschl G, Schuepbach WMM, Krack P, et al. Cost-effectiveness of neurostimulation in Parkinson\u2019s disease with early motor complications. Mov Disord. 2016;31:1183\u201391.","journal-title":"Mov Disord"},{"key":"999_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159340","volume":"11","author":"T Fundament","year":"2016","unstructured":"Fundament T, Eldridge PR, Green AL, Whone AL, Taylor RS, Williams AC, et al. Deep brain stimulation for Parkinson\u2019s disease with early motor complications: a UK cost-effectiveness analysis. PLoS ONE. 2016;11: 1\u201318.","journal-title":"PLoS ONE"},{"key":"999_CR18","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.1016\/j.wneu.2020.02.150","volume":"138","author":"JCY Fann","year":"2020","unstructured":"Fann JCY, Chang KC, Yen AMF, Chen SLS, Chiu SYH, Chen HH, et al. Cost-effectiveness analysis of deep brain stimulation for Parkinson disease in Taiwan. World Neurosurg [Internet]. 2020;138:e459\u201368. https:\/\/doi.org\/10.1016\/j.wneu.2020.02.150.","journal-title":"World Neurosurg [Internet]."},{"key":"999_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/mds.25407","volume":"28","author":"J Dams","year":"2013","unstructured":"Dams J, Siebert U, Bornschein B, Volkmann J, Deuschl G, Oertel WH, et al. Cost-effectiveness of deep brain stimulation in patients with Parkinson\u2019s disease. Mov Disord. 2013;28:763\u201371.","journal-title":"Mov Disord"},{"key":"999_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.wneu.2015.11.062","volume":"89","author":"Y Kawamoto","year":"2016","unstructured":"Kawamoto Y, Mouri M, Taira T, Iseki H, Masamune K. Cost-effectiveness analysis of deep brain stimulation in patients with Parkinson\u02bcs disease in Japan. World Neurosurg [Internet]. 2016;89:628\u201335. https:\/\/doi.org\/10.1016\/j.wneu.2015.11.062.","journal-title":"World Neurosurg [Internet]."},{"key":"999_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/ner.12474","volume":"19","author":"JB Pietzsch","year":"2016","unstructured":"Pietzsch JB, Garner AM, Marks WJ. Cost-effectiveness of deep brain stimulation for advanced Parkinson\u2019s disease in the United States. Neuromodulation. 2016;19:689\u201397. https:\/\/doi.org\/10.1111\/ner.12474.","journal-title":"Neuromodulation"},{"key":"999_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1227\/neu.0000000000002274","volume":"92","author":"X Guo","year":"2023","unstructured":"Guo X, Feng C, Pu J, Jiang H, Zhu Z, Zheng Z, et al. Deep brain stimulation for advanced Parkinson disease in developing countries: a cost-effectiveness study from China. Neurosurgery. 2023;92:812\u20139.","journal-title":"Neurosurgery"},{"key":"999_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/ane.13434","volume":"144","author":"JM Norlin","year":"2021","unstructured":"Norlin JM, Willis M, Persson U, Andersson E, P\u00e5lhagen SE, Odin P. Swedish guidelines for device-aided therapies in Parkinson\u2019s disease\u2014economic evaluation and implementation. Acta Neurol Scand. 2021;144:170\u20138.","journal-title":"Acta Neurol Scand"},{"key":"999_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00415-013-7148-z","volume":"261","author":"S Eggington","year":"2014","unstructured":"Eggington S, Valldeoriola F, Chaudhuri KR, Ashkan K, Annoni E, Deuschl G. The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson\u2019s disease. J Neurol. 2014;261:106\u201316.","journal-title":"J Neurol"},{"key":"999_CR25","unstructured":"Centre for Clinical Epidemiology and Evaluation | Vancouver Coastal Health Research Institute. Deep Brain Stimulation Or Duodopa For Advanced Parkinson Disease In British Columbia Health Technology Assessment Report [Internet]. 2017. https:\/\/www2.gov.bc.ca\/gov\/content\/health\/about-bc-s-health-care-system\/partners\/health-authorities\/bc-health-technology-assessment\/health-technology-assessments\/deep-brain-stimulation."},{"key":"999_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3171\/2018.4.JNS171909","volume":"131","author":"JA Hanna","year":"2019","unstructured":"Hanna JA, Scullen T, Kahn L, Mathkour M, Gouveia EE, Garces J, et al. Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson\u2019s disease: long-term outcomes with up to 7 years of follow-up. J Neurosurg. 2019;131:807\u201312.","journal-title":"J Neurosurg"},{"key":"999_CR27","doi-asserted-by":"crossref","unstructured":"Limousin P, Foltynie T. Long-term outcomes of deep brain stimulation in Parkinson disease. Nat Rev Neurol. 2019. 15:234\u201342.","DOI":"10.1038\/s41582-019-0145-9"},{"key":"999_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38555-2","author":"A Gessani","year":"2023","unstructured":"Gessani A, Cavallieri F, Fioravanti V, Campanini I, Merlo A, Di Rauso G, et al. Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson\u2019s disease. Sci Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-023-38555-2.","journal-title":"Sci Rep"},{"key":"999_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10072-023-07059-2","volume":"45","author":"D Genovese","year":"2024","unstructured":"Genovese D, Bove F, Rigon L, Tufo T, Izzo A, Calabresi P, et al. Long-term safety and efficacy of frameless subthalamic deep brain stimulation in Parkinson\u2019s disease. Neurol Sci. 2024;45:565\u201372.","journal-title":"Neurol Sci"},{"key":"999_CR30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/mds.29796","volume":"39","author":"HL Frequin","year":"2024","unstructured":"Frequin HL, Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, et al. Long-term follow-up of the LEAP study: early versus delayed levodopa in early Parkinson\u2019s disease. Mov Disord. 2024;39:975\u201382.","journal-title":"Mov Disord"},{"key":"999_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1227\/neu.0000000000002117","volume":"91","author":"HR Park","year":"2022","unstructured":"Park HR, Im HJ, Park J, Yoon BW, Lim YH, Song EJ, et al. Long-term outcomes of bilateral subthalamic nucleus deep brain stimulation for patients with Parkinson\u2019s disease: 10 years and beyond. Neurosurgery. 2022;91:726\u201333.","journal-title":"Neurosurgery"},{"key":"999_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2008.929","volume":"301","author":"FM Weaver","year":"2009","unstructured":"Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301:63\u201373.","journal-title":"JAMA"},{"key":"999_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/mds.22735","volume":"25","author":"E Moro","year":"2010","unstructured":"Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson\u2019 s disease. Mov Disord. 2010;25:578\u201386.","journal-title":"Mov Disord"},{"issue":"14","key":"999_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.parkreldis.2007.06.012","volume":"14","author":"C Wider","year":"2008","unstructured":"Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJG. Long-term outcome of 50 consecutive Parkinson \u2019 s disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord. 2008;14(14):114\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"999_CR35","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa035275","volume":"349","author":"K Paul","year":"2003","unstructured":"Paul K, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease. N Engl J Med. 2003;349:1925\u201334.","journal-title":"N Engl J Med"},{"key":"999_CR36","unstructured":"World Health Organization. Life tables by country-Egypt [Internet]. 2019. https:\/\/apps.who.int\/gho\/data\/view.main.60500. Accessed 20 Oct 2024."},{"key":"999_CR37","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/WNL.0b013e3181f61311","volume":"75","author":"EB Forsaa","year":"2010","unstructured":"Forsaa EB, Larsen JP, Wentzel-Larsen T, Alves G. What predicts mortality in Parkinson disease? A prospective population-based long-term study. Neurology. 2010;75:1270\u20136.","journal-title":"Neurology"},{"key":"999_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/362572","author":"A Contreras","year":"2012","unstructured":"Contreras A, Grandas F. Risk of falls in Parkinson\u2019s disease: a cross-sectional study of 160 patients. Parkinsons Dis. 2012. https:\/\/doi.org\/10.1155\/2012\/362572.","journal-title":"Parkinsons Dis"},{"key":"999_CR39","doi-asserted-by":"publisher","unstructured":"Schuepbach WMM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson\u2019s disease with early motor complications. N Engl J Med [Internet]. 2013;368:610\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1205158","DOI":"10.1056\/NEJMoa1205158"},{"key":"999_CR40","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1177\/0272989X15584921","volume":"35","author":"S Kent","year":"2015","unstructured":"Kent S, Gray A, Schlackow I, Jenkinson C, McIntosh E. Mapping from the Parkinson\u2019s disease questionnaire PDQ-39 to the generic EuroQol EQ-5D-3L. Med Decis Mak. 2015;35:902\u201311.","journal-title":"Med Decis Mak"},{"key":"999_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.36401\/JQSH-24-12","volume":"7","author":"M Gamal","year":"2024","unstructured":"Gamal M, Sedrak AS, Elsisi GH, Elagamy A, Seyam A, Eldebeiky M, et al. National recommendations for pharmacoeconomic evaluations reporting for reimbursement and procurement of new pharmaceutical applications in Egypt. Glob J Qual Saf Healthc. 2024;7:216\u201323.","journal-title":"Glob J Qual Saf Healthc"},{"key":"999_CR42","unstructured":"Central Bank of Egypt. Exchange Rates Historical Data. 2024."},{"key":"999_CR43","unstructured":"Medtronic. DBS THERAPY FOR PARKINSON\u2019S DISEASE. https:\/\/www.medtronic.com\/uk-en\/patients\/treatments-therapies\/deep-brain-stimulation-parkinsons-disease\/living-with-dbs\/replacing-your-device.html. 2024."},{"key":"999_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s42506-024-00159-7","author":"AN Fasseeh","year":"2024","unstructured":"Fasseeh AN, Korra N, Elezbawy B, Sedrak AS, Gamal M, Eldessouki R, et al. Framework for developing cost-effectiveness analysis threshold: the case of Egypt. J Egypt Public Health Assoc. 2024. https:\/\/doi.org\/10.1186\/s42506-024-00159-7.","journal-title":"J Egypt Public Health Assoc"},{"key":"999_CR45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/ane.12224","volume":"130","author":"B Lilleeng","year":"2014","unstructured":"Lilleeng B, Bronnick K, Toft M, Dietrichs E, Larsen JP. Progression and survival in Parkinson\u2019s disease with subthalamic nucleus stimulation. Acta Neurol Scand. 2014;130:292\u20138.","journal-title":"Acta Neurol Scand"},{"key":"999_CR46","unstructured":"Central Agency for Public Mobilization and Statistics. Average weekly cash wage in pounds in the public and private sector (in Arabic) [Internet]. 2022. https:\/\/www.capmas.gov.eg\/Pages\/IndicatorsPage.aspx?page_id=6152&ind_id=1100. Accessed 30 Oct 2024."}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-00999-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-025-00999-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-00999-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:43:56Z","timestamp":1768041836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-025-00999-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1007\/s40258-025-00999-0","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The data supporting this study\u2019s findings and the codes used in data analyses are available from the corresponding author upon reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and code availability"}},{"value":"Ethical approval was obtained from the ethics committee of Ain Shams University, Faculty of Medicine (No. FMASU R167\/2025).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Verbal informed consent was obtained prior to the interview.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent to publish is not required as the manuscript does not include any identifying personal data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H.R. designed and directed the project and was in charge of overall direction and planning\n                      .\n                      Z.H. designed the model and the computational framework and analyzed the data. A.M. verified the model and analytical methods. N.W. conducted the patient\u2019s interviews. H.R., A.M and N.W, contributed to the interpretation of the results. Z.H. took the lead in writing the manuscript with input from all authors. All authors provided critical feedback and helped shape the research, analysis and manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}